DIANA HAUSMAN

CIK 1563992 · Chief Medical Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

4

Total Filings

25

Lifetime Open-Market Net

-$3.21M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMRX Director 5,500 $4.19 $23.0K $19.9K 7 2026-06-11
ZNTL Chief Medical Officer 373,876 $3.75 $1.40M -$42.4K 3 2024-05-09
ZYME Chief Medical Officer 7,377 $22.88 $168.8K -$3.22M 10 2021-03-12
Cascadian Therapeutics, Inc. (ONTY) Delisted Chief Medical Officer 5,747 $26.7K 5 2015-09-28

Recent Filings · Page 2 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-03-12 ZYME Mixed +1,452 -$36.6K EDGAR
2021-01-11 ZYME Grant (A) +207 $6.4K EDGAR
2020-12-04 ZYME Mixed -$266.8K EDGAR
2020-12-03 ZYME Mixed -$830.8K EDGAR
2020-09-16 ZYME Mixed -$1.25M EDGAR
2020-07-06 ZYME Grant (A) +367 $11.3K EDGAR
2020-03-11 ZYME Grant (A) $0 EDGAR
2020-01-09 ZYME Grant (A) +332 $6.5K EDGAR
2019-07-10 ZYME Grant (A) +520 $6.5K EDGAR
2019-01-10 ZYME Grant (A) +499 $6.2K EDGAR
Showing 1120 of 25
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.